StockData
Cytokinetics Inc logo

Cytokinetics Inc (CYTK) stock

CYTKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$51.65−1.52 (-2.86%)

Close on Nov 17, 2026Market cap $7.18BP/E –Yield –

Cytokinetics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Cytokinetics's price to sales ratio was 0.1× on Nov 11, 2026, against 0.1× a year earlier. Over the last 5 years it ranged from 0.0× to 294.3×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×+0.0
2025Dec 31, 20250.1×−1.5
2024Dec 31, 20241.6×+0.5
2023Dec 29, 20231.0×+1.0
2022Dec 30, 20220.0×−0.1
2021Dec 31, 20210.2×+0.1
2020Dec 31, 20200.0×−15.3
2019Apr 30, 201915.3×−0.2
2018Dec 31, 201815.5×+6.1
2017Dec 29, 20179.4×+3.5
2016Dec 30, 20165.9×−4.0
2015Dec 31, 201510.0×+4.1
2014Dec 31, 20145.9×−16.7
2013Dec 31, 201322.6×+7.3
2012Dec 31, 201215.3×−0.7
2011Dec 30, 201116.0×+14.5
2010Dec 31, 20101.5×–

More Cytokinetics figures

See a number that looks wrong?